Presented by: Shaheen Hamdy, MB ChB, PhD, FRCP & Cari Manypenny, M.S., CCC-SLP
This on-demand course is offered for free thanks to the sponsorship support from Phagenesis.
Audience: Medical SLP
Description: Pharyngeal Electrical Stimulation (PES) is a neurostimulation therapy developed from decades of research investigating the cortical control of swallowing and the role of neuroplasticity in swallowing recovery. In this webinar, presenters will review the key mechanistic studies that led to the development of PES and discuss how these principles translate into clinical practice. Attendees will gain an overview of PES treatment delivery, patient selection considerations, clinical evidence in severe post-stroke dysphagia, and recent guideline inclusion. This session is designed for clinicians seeking a deeper understanding of the neuroscience, mechanism of action, and clinical evidence supporting PES.
Learning Objectives:
- Describe the cortical control of swallowing and explain how pharyngeal electrical stimulation modulates sensorimotor pathways to promote neuroplastic reorganization and swallowing recovery after neurological injury.
- Identify key clinical studies, outcomes, and recent guideline developments supporting the use of PES in severe post-stroke dysphagia.
- Discuss practical considerations for PES treatment delivery, patient selection, and integration into acute and critical care dysphagia management pathways.
This webinar is approximately 60 minutes in length. This is a recording of a live webinar.
This webinar is offered for Professional Development Hours (PDHs), previously Certification Maintenance Hours (CMHs). For more info: https://www.asha.org/certification/factdef/.
Certificate of completion available for download at the completion of the webinar.
This video does not have an expiration date.
About the Presenters:
Dr./Prof. Shaheen Hamdy is Emeritus Professor of Neurogastroenterology based at the University of Manchester, Co-Founder and Chief Scientific Officer of Phagenesis, a company devoted to restoring swallowing control. Dr. Hamdy’s research work has characterised the role of therapeutic interventions in the human swallowing system, with a particular interest in neurostimulation. His research has attracted >£5 million in grant income, publishing over 120 peer-reviewed research papers with a H factor of 70, and contributing to 12 books.
Relevant Disclosures: Emeritus Professor at the University of Manchester; CSO of Phagenesis Ltd, for which I hold stocks and shares. Received honorarium from Khon Kaen University (KKU) for a lecture series in 2025.
Cari Manypenny, M.S., CCC-SLP, is Associate Director, Medical Affairs at Phagenesis and a medical speech-language pathologist with 17 years of experience specializing in neurogenic dysphagia and stroke rehabilitation. Her work focuses on clinical education, dysphagia innovation, and supporting evidence-based swallowing rehabilitation.
Relevant Disclosures: Full-time employee at Phagenesis.
If you have any questions, please contact us here.
